I work as an engineer, donate 10% of my income, and occasionally enjoy doing independent research. Iâm most interested in farmed animal welfare and the nitty-gritty details of global health and development work. In 2022, I was a co-winner of the GiveWell Change Our Mind Contest.
MHRđ¸
Good information!
A couple things to add to this very good comment:
In general, the landscape of charity evaluation for animal charities is less mature and quite a bit more uncertain than the landscape for global health and development charities. Any cost-effectiveness estimates are going to be coarse and debatable.
ACE has a partially qualitative cost-effectiveness scoring system. Their ratings (higher = better) for their recommended charities are:
Faunalytics: 5.7
New Roots Institute: 4.9
The Humane League: 4.7
Wild Animal Initiative: 4.5
Ăiftlik HayvanlarÄąnÄą Koruma DerneÄi: 4.3
Shrimp Welfare Project: 4.3
Fish Welfare Initiative: 4.3
Sinergia Animal: 4.1
Good Food Institute: 3.8
Dansk Vegetarisk Forening: 3.7
Legal Impact for Chickens: 3.7
@Laura Duffy wrote a report at Rethink Priorities in which she estimated that corporate hen welfare campaigns avert 1.13 DALYs/â$ and shrimp stunning interventions avert 0.038 DAYLYs/â$. Both of these estimates were quite uncertain and depended on a lot of debatable assumptions (including possibly underrating the potential for shrimp stunning interventions to catalyze industry-wide changes), but I think this is one of the best estimates currently out there.
My personal advice would be that I think the EA Funds Animal Welfare Fund is probably the expected value maximizing option, while The Humane League is probably the best option if youâre somewhat risk-averse.
Some data from open phil and EA funds grants:
Shrimp Welfare Project :
Open Philanthropy (September 2022): $300,000
Open Philanthropy (November 2023): $2,000,000
EA Funds (Q1 2022): $45,000
EA Funds (Q1 2022): $45,000
EA Funds (Q4 2022): $210,000
EA Funds (Q3 2023): $130,000
Insect Institute:
None listed
Arthropoda Foundation:
None listed
Aquatic Life Institute:
Open Philanthropy (June 2022): $100,000
Open Philanthropy (November 2022): $150,000
Open Philanthropy (December 2023): $550,000
EA Funds (Q1 2022): $80,000
EA Funds (Q1 2022): $80,000
EA Funds (Q3 2022): $80,000
EA Funds (Q4 2022): $200,000
Crustacean Compassion:
Open Philanthropy (February 2021): $786,830
Open Philanthropy (January 2023): $863,595
EA Funds (Q3 2021): $92,000
EA Funds (Q3 2022): $59,000
EA Funds (Q3 2023): $2171
EA Funds (Q4 2023): $84,000
IMO if EA funds isnât representative of EA, Iâm not sure what is. I think the different funds do a good job of accurately representing the broad diversity of viewpoints and approaches within the community, and I would personally be very sad if EA funds dropped the EA branding.
Agreed that this seems surprisingly under-discussed
Thanks so much for your response, that all makes sense!
Youâre understanding question 3 correctlyâGiveWellâs moral weights look like the following, which is fairly different from valuing every year of life equally.
Thanks so much for going on the podcast and for the incredible work that you and everyone involved in r.i.c.e. are doing! Itâs amazing that youâve been able to save so many lives so cost-effectively. I did have a few questions I was curious about though:
In discussing your room for more funding, you mentioned likely cost-effectiveness improvements from economies of scale as the program grows. That makes complete sense to me on the current margin, but Iâm curious if you have thoughts about how the cost-effectiveness might change if the program were to scale up say an order of magnitude. It seems like both r.i.c.e.âs staff and the medical college staff are exceptionally engaged and motivated. Do you sense of how important thatâs been to the programâs success, and of whether that would be hard to maintain and replicate if the program expanded substantially more broadly? I know that for example in early childhood education interventions, thereâs quite a bit of evidence of negative scale-up effects where programs that look really great in pilots have ended up looking a lot less good when implemented at large scale. (This isnât at all intended to be a negative on r.i.c.e.âs current or near-term work, Iâm just curious how optimistic or non-optimistic to be about the larger potential of kangaroo mother care programs)
In talking about why this program wasnât done before r.i.c.e.âs intervention and why it isnât done in more places, you said âThere are just a few paediatricians who work there, and they had just a few nurses working with them. And thatâs just not going to be enough for this many babies. The government of Uttar Pradesh recognises this; the Department of Medical Education is working hard to open more new medical colleges and new nursing colleges.â Given that context, do you worry that part of what r.i.c.e is doing in the short-run is reallocating medical care from being provided to other people to being provided to the babies in the program? I of course donât think this is an argument for r.i.c.e. being ineffectiveâI think there are strong reasons to think that the care youâre providing is doing more good than the counterfactual use of the nursesâ time, and that in the long-run the supply of nurses is relatively elastic. But Iâm curious if this might be a reason to think the program is less cost-effective than it initially appears.
GiveWellâs moral weights take a time-relative interest account-like approach to the value of a human life, in which saving the life of a newborn infant is weighted as moderately less valuable than saving the life of an older child. This leads to GiveWell estimating r.i.c.e.âs cost-effectiveness as about 30% lower than it would have been if they had weighted preventing infant deaths as equally valuable as preventing the deaths of older children. Do you personally have any thoughts about the right approach to making these kinds of difficult tradeoffs when evaluating different charities? And how important a consideration do you think this moral weight question is for donors who are considering donating to r.i.c.e. vs. GiveWellâs current top charities.
Hm I donât obviously see the analogy with the common appâhiring employees and admitting students seem quite different.
Are there antitrust concerns with multiple orgs (even if nonprofit) using a common screener?
FYI you described the âElectric Shrimp Stunning: a Potential High-Impact Donation Opportunityâ post as âSWPâs CEA of stunners,â but I have no affiliation with SWP.
I agree with this comment. Itâs worth nothing that the methodology used in this analysis isnât the same as the methodology used in the CURVE sequence. In the âHow Can Risk Aversion Affect Your Cause Prioritizationâ report, @Laura Duffy weighted 1 year of disabling pain at 2 to 10 DALYs and 1 year of excruciating pain at 60 to 150 DALYs. I expect that dying is at least disablingly painful and potentially excruciatingly painful, so these weights would imply a >5x improvement in cost-effectiveness (but even at the upper end, this probably wouldnât be cost-competitive with top EA interventions).
In general, I think itâs a good step to try and actually put interventions from different cause areas on the same scale, but I continue to think that because DALYs are a unit of health status and not a unit of utility, trying to use them as a unit of comparison is unlikely to be optimal (see here and here for more)
This is great work on a really sad topic. Well done putting this together
Thanks!
Has RP published anything laying out its current plans for funding and/âor executing work on AI governance and existential risk? I was surprised to see that no RP team members are listed under existential security or AIGS anymore. Is RPâs plan going forward that all work in these areas will be carried out by special projects initiatives rather than the core RP team? And how does that relate to funding? When RP receives unrestricted donor funds, are those sometimes regranted to incubated orgs within special projects?
Fantastic and important work (as always)!
Figure 3 is somewhat concerningâif I squint I can sort of see some vague agreement between the different sources, but itâs pretty all over the place. Do you have a sense of whether this is an area where funding additional field research would be a good idea, or do you think this is lower-priority than other potential research questions related to shrimp welfare?
Thanks for your response! Thatâs very interesting (and scary)
@Aaron Bergmanâs Pigeon Hour gets close to this https://ââwww.aaronbergman.net/ââpodcast
Hereâs the Cochrane withdrawal notice.
Looks like they plagiarized from this paper, which found:
Results: Thirteen placebo-controlled comparisons have examined the therapeutic effect of zinc lozenges on common cold episodes of natural origin. Five of the trials used a total daily zinc dose of less than 75 mg and uniformly found no effect. Three trials used zinc acetate in daily doses of over 75 mg, the pooled result indicating a 42% reduction in the duration of colds (95% CI: 35% to 48%). Five trials used zinc salts other than acetate in daily doses of over 75 mg, the pooled result indicating a 20% reduction in the duration of colds (95% CI: 12% to 28%).
Thanks Vasco!
I checked the pages for each charity to get the scores.
I agree that AWF doesnât directly evaluate cost-effectiveness, but I still think thereâs a good chance theyâre likely to be the EV maximizing option over THL. THL estimates that it costs them $2.63 to move a hen from a conventional to a cage-free system, or about 0.57 yr/â$ given a 1.5-year lifespan. Last year, Emily Oehlsen from Open Phil said âWe think that the marginal [farmed animal welfare] funding opportunity is ~1/â5th as cost-effective as the average from Sauliusâ analysis.â Sauliusâs 2019 analysis estimated that corporate campaigns pre-2019 impacted 41 chicken-years per dollar, so at a 5x reduction thatâs 8.2 yr/â$. I donât want to take Emilyâs numbers too literally, but that implies a >10x gap between the cost effectiveness values of OPâs marginal funding opportunity and THL. Since Iâd expect AWFâs opportunities to look somewhat similar to OPâs, that leads me to guess that theyâre likely to be on net more cost-effective than THL. This directionally agrees with some of the comments by insiders such as @James Ăzden on the GWWC evaluations thread as well. But Iâd be very curious to hear more from folks who are more plugged in, this is just an outsiderâs guess.
For what itâs worth, I do actually give to both AWF and THL, but give much more to AWF.